New decree gives better access to exceptional use drugs in Spain
This article was originally published in Scrip
Spanish doctors will no longer have to seek permission from the national medicines agency, AEMPS, for off-label prescribing, according to a new royal decree.
You may also be interested in...
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.